Topoisomerase IV is a target of quinolones in Escherichia coli.
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
We have demonstrated that, in Escherichia coli, quinolone antimicrobial agents target topoisomerase IV (topo IV). The inhibition of topo IV becomes apparent only when gyrase is mutated to quinolone resistance. In such mutants, these antibiotics caused accumulation of replication catenanes, which is diagnostic of a loss of topo IV activity. Mutant forms of topo IV provided an additional 10-fold resistance to quinolones and prevented drug-induced catenane accumulation. Drug inhibition of topo IV differs from that of gyrase. (i) Wild-type topo IV is not dominant over the resistant allele. (ii) Inhibition of topo IV leads to only a slow stop in replication. (iii) Inhibition of topo IV is primarily bacteriostatic. These differences may result from topo IV acting behind the replication fork, allowing for repair of drug-induced lesions. We suggest that this and a slightly higher intrinsic resistance of topo IV make it secondary to gyrase as a quinolone target. Our results imply that the quinolone binding pockets of gyrase and topo IV are similar and that substantial levels of drug resistance require mutations in both enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Self-citationNew topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
DNA topoisomerases: why so many?
Wang, J. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89545-3 · Cited by 363
Kreuzer, K. N., & Cozzarelli, N. R. (1979) · Journal of Bacteriology · doi:10.1128/jb.140.2.424-435.1979 · Cited by 337
Self-citationSite-directed insertion and deletion mutagenesis with cloned fragments in Escherichia coli
Winans, S. C., Elledge, S. J., Krueger, J. H., & Walker, G. C. (1985) · Journal of Bacteriology · doi:10.1128/jb.161.3.1219-1221.1985 · Cited by 336
Peng, H., & Marians, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80551-1 · Cited by 261
Unlinking of DNA by Topoisomerases During DNA Replication
Ullsperger, C., Vologodskii, A. V., & Cozzarelli, N. R. (1995) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-79488-9_6 · Cited by 83
Self-citation
Cited by
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments
Hopkins, K. L., Davies, R. H., & Threlfall, E. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.02.006 · Cited by 557
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
Hooper, D. C. (2001) · Clinical Infectious Diseases · doi:10.1086/319370 · Cited by 517
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2020) · Molecules · doi:10.3390/molecules25235662 · Cited by 413
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Levine, C., Hiasa, H., & Marians, K. J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00126-2 · Cited by 391
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Van Bambeke, F., Michot, J.-M., Van Eldere, J., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342
Roles of Topoisomerases in Maintaining Steady-state DNA Supercoiling in Escherichia coli
Zechiedrich, E. L., Khodursky, A. B., Bachellier, S., Schneider, R., Chen, D., Lilley, D. M. J., & Cozzarelli, N. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8103 · Cited by 328
Self-citationGenomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli
Peter, B. J., Arsuaga, J., Breier, A. M., Khodursky, A. B., Brown, P. O., & Cozzarelli, N. R. (2004) · Genome Biology · doi:10.1186/gb-2004-5-11-r87 · Cited by 323
Self-citationFluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Mode of Action of Fluoroquinolones
Hooper, D. C. (1999) · Drugs · doi:10.2165/00003495-199958002-00002 · Cited by 290
Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli.
Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Genes & Development · doi:10.1101/gad.9.22.2859 · Cited by 290
Self-citationMechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 288
Wang, H., Dzink-Fox, J. L., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Topological challenges to DNA replication: Conformations at the fork
Postow, L., Crisona, N. J., Peter, B. J., Hardy, C. D., & Cozzarelli, N. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111006998 · Cited by 279
Self-citationBenchmarking AlphaFold‐enabled molecular docking predictions for antibiotic discovery
Wong, F., Krishnan, A., Zheng, E. J., Stärk, H., Manson, A. L., Earl, A. M., Jaakkola, T., & Collins, J. J. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211081 · Cited by 284
“…dnaE , rpoABCEZ , murA , and murF ) of the 12 essential proteins tested for the inclusive binding affinity threshold of − 5 kcal/mol and for 9 essential proteins ( gyrAB , dnaG , dnaB , ligA , rpoABCEZ , glmU , murA , murD , and murF ) for the stringent binding affinity threshold of − 7 kcal/mol…”
Background
Metadata
- Authors
- Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-12-05
- Volume
- 92
- Issue
- 25
- Pages
- 11801-11805
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1997755659
- Cited by
- 378
- References
- 13
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.